rs5883

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000078.3(CETP):​c.861C>T​(p.Phe287Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0536 in 1,614,184 control chromosomes in the GnomAD database, including 2,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.065 ( 399 hom., cov: 32)
Exomes 𝑓: 0.052 ( 2288 hom. )

Consequence

CETP
NM_000078.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.649

Publications

68 publications found
Variant links:
Genes affected
CETP (HGNC:1869): (cholesteryl ester transfer protein) The protein encoded by this gene is found in plasma, where it is involved in the transfer of cholesteryl ester from high density lipoprotein (HDL) to other lipoproteins. Defects in this gene are a cause of hyperalphalipoproteinemia 1 (HALP1). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
CETP Gene-Disease associations (from GenCC):
  • cholesterol-ester transfer protein deficiency
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-56973441-C-T is Benign according to our data. Variant chr16-56973441-C-T is described in ClinVar as Benign. ClinVar VariationId is 319984.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.649 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CETPNM_000078.3 linkc.861C>T p.Phe287Phe synonymous_variant Exon 9 of 16 ENST00000200676.8 NP_000069.2
CETPNM_001286085.2 linkc.750+1358C>T intron_variant Intron 8 of 14 NP_001273014.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CETPENST00000200676.8 linkc.861C>T p.Phe287Phe synonymous_variant Exon 9 of 16 1 NM_000078.3 ENSP00000200676.3
CETPENST00000379780.6 linkc.750+1358C>T intron_variant Intron 8 of 14 1 ENSP00000369106.2
CETPENST00000566128.1 linkc.666C>T p.Phe222Phe synonymous_variant Exon 9 of 16 5 ENSP00000456276.1
CETPENST00000569082.1 linkn.*73C>T downstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.0648
AC:
9861
AN:
152190
Hom.:
399
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.106
Gnomad AMI
AF:
0.0866
Gnomad AMR
AF:
0.0403
Gnomad ASJ
AF:
0.122
Gnomad EAS
AF:
0.00115
Gnomad SAS
AF:
0.0368
Gnomad FIN
AF:
0.0354
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.0533
Gnomad OTH
AF:
0.0574
GnomAD2 exomes
AF:
0.0513
AC:
12897
AN:
251464
AF XY:
0.0500
show subpopulations
Gnomad AFR exome
AF:
0.107
Gnomad AMR exome
AF:
0.0294
Gnomad ASJ exome
AF:
0.129
Gnomad EAS exome
AF:
0.000489
Gnomad FIN exome
AF:
0.0396
Gnomad NFE exome
AF:
0.0568
Gnomad OTH exome
AF:
0.0638
GnomAD4 exome
AF:
0.0525
AC:
76707
AN:
1461876
Hom.:
2288
Cov.:
33
AF XY:
0.0520
AC XY:
37795
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.111
AC:
3720
AN:
33480
American (AMR)
AF:
0.0308
AC:
1378
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.124
AC:
3233
AN:
26136
East Asian (EAS)
AF:
0.000453
AC:
18
AN:
39698
South Asian (SAS)
AF:
0.0380
AC:
3276
AN:
86258
European-Finnish (FIN)
AF:
0.0441
AC:
2356
AN:
53410
Middle Eastern (MID)
AF:
0.0650
AC:
375
AN:
5768
European-Non Finnish (NFE)
AF:
0.0532
AC:
59115
AN:
1112006
Other (OTH)
AF:
0.0536
AC:
3236
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
4399
8797
13196
17594
21993
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2204
4408
6612
8816
11020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0648
AC:
9864
AN:
152308
Hom.:
399
Cov.:
32
AF XY:
0.0611
AC XY:
4554
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.106
AC:
4408
AN:
41550
American (AMR)
AF:
0.0402
AC:
616
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.122
AC:
424
AN:
3470
East Asian (EAS)
AF:
0.00116
AC:
6
AN:
5190
South Asian (SAS)
AF:
0.0375
AC:
181
AN:
4830
European-Finnish (FIN)
AF:
0.0354
AC:
376
AN:
10618
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0533
AC:
3625
AN:
68022
Other (OTH)
AF:
0.0587
AC:
124
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
490
981
1471
1962
2452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0601
Hom.:
1296
Bravo
AF:
0.0680
Asia WGS
AF:
0.0260
AC:
89
AN:
3478
EpiCase
AF:
0.0545
EpiControl
AF:
0.0593

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 17, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28008009, 22403620, 24393849) -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BA1 -

Hyperalphalipoproteinemia 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
5.5
DANN
Benign
0.76
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5883; hg19: chr16-57007353; COSMIC: COSV52362633; COSMIC: COSV52362633; API